🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2855005 F VA 08/21/2025 COVID19
 PFIZER\BIONTECH
Influenza like illness, Lymphadenopathy, Mammogram Influenza like illness, Lymphadenopathy, Mammogram
Generic flu like symptoms; lymph node enlargement; This is a spontaneous report received from an Oth... Generic flu like symptoms; lymph node enlargement; This is a spontaneous report received from an Other HCP. A female patient received BNT162b2 (BNT162B2 NOS), in 2023 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 2021, for covid-19 immunization, reaction(s): "Generic flu like symptoms", "Lymph node enlargement"; Bnt162b2 (DOSE 2, SINGLE), administration date: 2022, for covid-19 immunization, reaction(s): "Generic flu like symptoms", "Lymph node enlargement". The following information was reported: LYMPHADENOPATHY (non-serious), outcome "recovered", described as "lymph node enlargement"; INFLUENZA LIKE ILLNESS (non-serious), outcome "recovered", described as "Generic flu like symptoms". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Reporter had some side effects, to the extent where, she was no longer going to take the mrna vaccine. Clarified, there were 2 different side effects. There were 2 side effects, that would usually occur every time she got Covid vaccine, back in 2021, 2022, 2023. That is what reporter was guessing. This occurred when getting 2 dose primary series, occurring both with first and second doses, with third booster dose, got a little bit of it but, was not as much as first and second primary doses. Guessing about the 2021, 2022 and 2023. They were back to back. reporter were thinking it started with first Covid pandemic, which was back in 2020, did not remember if 2020 or 2021 but put 2021, 2022 and 2023, to the best of their knowledge. The lymph node enlargement required her to get a mammogram, and lasted about 6 months. Believes reporter recovered from it. Clarified second side effect as, just generic flu like symptoms, lasted about 4 days. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500165794 same patient, different dose;US-PFIZER INC-202500165859 same patient, different dose; More
2855006 59 F NY 08/21/2025 COVID19
 PFIZER\BIONTECH
 EW0170
Pyrexia Pyrexia
bad fever; This is a spontaneous report received from a Consumer or other non HCP. A 59-year-old fe... bad fever; This is a spontaneous report received from a Consumer or other non HCP. A 59-year-old female patient received BNT162b2 (BNT162B2), on 20Apr2021 as dose 2, single (Lot number: EW0170) at the age of 59 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot: ER8733; anatomical location:Upper arm, pretty sure right arm.), administration date: 30Mar2021, when the patient was 59-year-old, for COVID-19 Immunization, reaction(s): "heart palpitations". The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "bad fever". Additional information: Patient takes vitamins but stopped for a while. Caller stated well now, but nothing back in 2021 doesn't believe. Did the patient receive any other vaccines on the same date as the Pfizer vaccine reported as No. Did the patient receive any other vaccines within 4 weeks prior to the first administration of the suspect vaccine reported as No. More
2855007 M GA 08/21/2025 COVID19
 PFIZER\BIONTECH
Body temperature, COVID-19, Drug ineffective, SARS-CoV-2 test Body temperature, COVID-19, Drug ineffective, SARS-CoV-2 test
second time testing positive for Covid; second time testing positive for Covid; This is a spontaneou... second time testing positive for Covid; second time testing positive for Covid; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A 73-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Paxlovid for COVID-19, reaction(s): "Dysgeusia (metal taste)"; Paxlovid for COVID-19, reaction(s): "diarrhea"; Paxlovid for COVID-19, reaction(s): "Felt nauseated but didn't vomit"; Paxlovid for COVID-19, reaction(s): "lost his appetite". Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Flu vaccine (flu vaccine decades ago, got a shot in the arm), administration date: 2000, when the patient was 49 years old, for Immunization, reaction(s): "AMPPE"; Flu vaccine (After treatment with high dose steroids, I was able to regain my vision, got a shot in the arm, Name of steroids unknown.), administration date: 2000, when the patient was 49 years old, for Immunization, reaction(s): "lost my central vision"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 nos (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "second time testing positive for Covid". The patient underwent the following laboratory tests and procedures: Body temperature: maybe .1 or .2 increase; SARS-CoV-2 test: Positive, notes: The second time. Therapeutic measures were not taken as a result of drug ineffective, covid-19. The patient had original 2 doses and believed he had had 3 boosters. He had contracted Covid twice after the Covid vaccine and boosters. The second time testing positive for Covid, the patient called his doctor on a Friday and he called in script for child dosage of Paxlovid, but he was unable to obtain it. On Monday he called his doctor back and said no one had Paxlovid and can't get it. The doctor asked him how he felt and his temperature was maybe .1 or .2 increase. His doctor said if you are not running a high fever and feel ok don't bother taking it and caller didn't take it the second time. Then he was fine after and his symptoms improved. He didn't need any other treatment.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500166339 same patient/event, different dose; More
2855008 F MO 08/21/2025 COVID19
 PFIZER\BIONTECH
Feeling cold Feeling cold
body became very cold; This is a spontaneous report received from a Consumer or other non HCP. A fe... body became very cold; This is a spontaneous report received from a Consumer or other non HCP. A female patient received BNT162b2 (BNT162B2), in 2021 as dose number 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING COLD (non-serious) with onset 2021, outcome "recovered" (2021), described as "body became very cold". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. Additional information: The consumer told company representative about her experience with Pfizer Covid vaccine from 2021. Felt like he would just call it in, to be safe. When asked to provide experience reporter had reported to caller, he states, she relayed that, pretty immediately after she received her vaccination, her body became very cold for about 2 minutes, then subsided. That was really the only detail that was provided. Caller had asked her if she felt like it was chills, said it was not really chills, whole body felt cold. Caller did not know how to describe that. Reporter was mentally having to recall when this occurred. Was with her first Covid vaccine, which became available in 2021, caller believed. Clarified, as previously stated, was from 4 years ago, was not a recent event. More
2855009 F OR 08/21/2025 COVID19
 PFIZER\BIONTECH
Fasciitis Fasciitis
fasciitis in her lower leg; This is a spontaneous report received from a Nurse from medical informat... fasciitis in her lower leg; This is a spontaneous report received from a Nurse from medical information team. A 75-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 22Oct2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (dose 1, lot unknown), administration date: 07Mar2021, for covid-19 immunisation; Bnt162b2 (dose 2, lot unknown), for covid-19 immunisation; Bnt162b2 (dose 3, lot unknown), for covid-19 immunisation; Bnt162b2 (dose 4, lot unknown), for covid-19 immunisation; Bnt162b2 (dose 5, lot unknown), for covid-19 immunisation; Bnt162b2 (dose 6, lot unknown), for covid-19 immunisation. Her first Pfizer COVID-19 vaccine was on 07Mar2021 and stated that she already had at least seven Pfizer COVID-19 vaccines. The following information was reported: FASCIITIS (non-serious) with onset Oct2024, 1 week after the suspect product(s) administration, outcome "unknown", described as "fasciitis in her lower leg". The event "fasciitis in her lower leg" required physician office visit. Therapeutic measures were taken as a result of fasciitis. She also stated that she had Physical therapy and anti-inflammatory medications. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2855010 08/21/2025 COVID19
 PFIZER\BIONTECH
COVID-19, Drug ineffective COVID-19, Drug ineffective
COVID; COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A... COVID; COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 73-year-old patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2024, outcome "unknown" and all described as "COVID". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2855011 59 F MD 08/21/2025 COVID19
 PFIZER\BIONTECH
 FH8030
COVID-19, Drug ineffective, Weight COVID-19, Drug ineffective, Weight
had actual Covid - bad case but not hospitalized; had actual Covid - bad case but not hospitalized; ... had actual Covid - bad case but not hospitalized; had actual Covid - bad case but not hospitalized; This is a spontaneous report received from a Consumer or other non HCP. A 60-year-old female patient received BNT162b2 (BNT162B2), on 16Apr2021 as dose 1, single (Lot number: EW0164), in arm, on 07May2021 as dose 2, single (Lot number: EW0165), in arm and on 26Nov2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 59 years, in arm, all intramuscular for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), in 2023 as dose number unknown (booster), single intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Strong Menopause symptoms" (unspecified if ongoing). There were no concomitant medications (the patient did not receive any other vaccines within 4 weeks prior to the first administration of the suspect vaccine, and did not receive any other vaccines on the same date as the Pfizer vaccine). The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "had actual Covid - bad case but not hospitalized". The patient underwent the following laboratory tests and procedures: Weight: 160. Clinical course: had actual Covid-bad case but not hospitalized in early 2023. More
2855012 M MD 08/21/2025 DTP
IPV
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER

Contraindicated product administered, Injection site erythema, Injection site in... Contraindicated product administered, Injection site erythema, Injection site inflammation, Injection site pain, Injection site warmth; Contraindicated product administered, Injection site erythema, Injection site inflammation, Injection site pain, Injection site warmth More
Contraindicated drug combination administered; received the polio and Dtap vaccines, is red; receive... Contraindicated drug combination administered; received the polio and Dtap vaccines, is red; received the polio and Dtap vaccines, is red and inflamed; area around his bicep is hot; area around his bicep is hot and painful to touch; Initial information received on 05-Aug-2025 regarding an unsolicited valid non-serious case received from the patient's mother. This case involves a 4 years old male patient who received the polio and dtap vaccines, is red and inflamed, and area around his bicep is hot and painful to touch while receiving vaccines DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE and POLIOMYELITIS VACCINE (INACTIVATED) and while treated with DUPILUMAB [DUPIXENT] via a prefilled pen. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking DUPIXENT (DUPILUMAB) Solution for injection(strength:300 mg) at a dose of 300 mg Q4W subcutaneous for Product used for unknown indication. On 04-Aug-2025, the patient received a dose of suspect DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE. On 04-Aug-2025, the patient received a dose of suspect POLIOMYELITIS VACCINE (INACTIVATED) On 04-AUG-2025 the patient developed a non-serious event "received the polio and dtap vaccines, is red and inflamed" (vaccination site inflammation) (Vaccination site erythema ) (unknown latency) following the first dose intake (unknown batch number and expiry date) of DUPILUMAB,POLIOMYELITIS VACCINE (INACTIVATED) and DIPHTHERIA and TETANUS AND NOS PERTUSSIS VACCINE. On 04-AUG-2025 the patient developed a non-serious event "area around his bicep is hot and painful to touch" (vaccination site pain) (unknown latency) following the first dose intake (unknown batch number and expiry date) of DUPILUMAB,POLIOMYELITIS VACCINE (INACTIVATED) and DIPHTHERIA and TETANUS AND NOS PERTUSSIS VACCINE. On an unknown date the patient developed a non-serious event "contraindicated drug combination administered" (contraindicated product administered) (unknown latency) following the first dose intake (unknown batch number and expiry date) of DUPILUMAB,POLIOMYELITIS VACCINE (INACTIVATED) and DIPHTHERIA and TETANUS AND NOS PERTUSSIS VACCINE. Information regarding the batch number and expiration date corresponding to the one at the time of event occurrence was requested. It was reported "he was given four vaccines on 0814/2025. Two shots on each shoulder. Mother reported the patient left shoulder where he received the polio and Dtap vaccines, is red and inflamed. Mother reported the area around his bicep is hot and painful to touch. Mother consented for the provider to be contacted and provided both the dermatologist and pediatrician information" Action taken with DUPILUMAB (DUPIXENT) was unknown for all events. Action taken with POLIOMYELITIS VACCINE (INACTIVATED) (POLIOMYELITIS VACCINE (INACTIVATED)) and DIPHTHERIA, TETANUS AND PERTUSSIS (NOS) VACCINE was not applicable for all events. Corrective treatment:Not reported for all events. Outcome: Unknown for all events This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2855013 NC 08/21/2025 DTAPIPVHIB
 SANOFI PASTEUR
Product preparation issue Product preparation issue
inappropriate use due to the hib portion of pentacel was administered to a patient without first rec... inappropriate use due to the hib portion of pentacel was administered to a patient without first reconstituting with the dtap-ipv portion with no reported adverse event; Initial information received on 19-Aug-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient with inappropriate use due to the hib portion of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel(VERO)]l was administered to a patient without first reconstituting with the dtap-ipv portion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received inappropriate use due to the hib portion of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine Powder and suspension for suspension for injection (strength, dose, batch and expiry date unkown) via unknown route in unknown administration site for Immunisation without first reconstituting with the dtap-ipv portion with no reported adverse event (single component of a two-component product administered) (same day latency). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Reportedly, One of the clinic nurses mistakingly used the Hib vial (green top) And did not reconstitute it with the contents in the corresponding blue capped vial. Action taken- not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2855014 28 M 08/21/2025 ANTH
 EMERGENT BIOSOLUTIONS
 300212A
Expired product administered, No adverse event Expired product administered, No adverse event
Patient came in for 3 immunizations, one being Anthrax. Upon reading the expiration date, it was rea... Patient came in for 3 immunizations, one being Anthrax. Upon reading the expiration date, it was read wrong. The sticker annotating when it was opened cause some confusion as well. The patient has had no adverse effects to the immunization. More
2855015 63 F TN 08/21/2025 PNC20
 PFIZER\WYETH
 LJ5284
Unevaluable event Unevaluable event
NONE NONE
2855016 5 F OH 08/21/2025 DTAP
IPV
 GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
 223Y9
Y1D03P1
Eye movement disorder, Visual acuity tests; Eye movement disorder, Visual acuity... Eye movement disorder, Visual acuity tests; Eye movement disorder, Visual acuity tests More
Parents noticed tic like movements of patient's eyes, frequently moving both eyes right superol... Parents noticed tic like movements of patient's eyes, frequently moving both eyes right superolateral. Random frequency. No visual disturbance. No other neurologic symptoms. Behavior slightly more irritable after the immunizations, otherwise normal behavior. Patient evaluated by me on 8/20/25, noted to be of her normal behavior, unchanged from day of vaccine (I saw her that day also). Vision screen unchanged from 8/13/25. Observed to have tic like movements of both eyes to right superolateral. Eye exam otherwise normal. No nystagmus, able to follow finger with her eyes appropriately. Being referred to pediatric neurology. More
2855017 4 M FL 08/21/2025 DTAPIPV
DTAPIPV
MMRV
MMRV
 SANOFI PASTEUR
SANOFI PASTEUR
MERCK & CO. INC.
MERCK & CO. INC.
 U8198AA
U8198AA
Z005150
Z005150
Cough, Heart rate increased, Nausea, Pruritus, Throat tightness; Urticaria; Coug... Cough, Heart rate increased, Nausea, Pruritus, Throat tightness; Urticaria; Cough, Heart rate increased, Nausea, Pruritus, Throat tightness; Urticaria More
Patient returned about 45 minutes after vaccines were given with coughing and full body hives. He wa... Patient returned about 45 minutes after vaccines were given with coughing and full body hives. He was nauseated. He said he felt like his throat was being squeezed. Very itchy. HR slightly increased (115 bpm) but O2 was normal. Patient was given epinephrine IM as well as Benadryl for suspected anaphylaxis. He recovered and was sent home. No issues following. Had never had a reaction to a previous vaccine. More
2855018 17 F PA 08/21/2025 MENB
MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
 49N9M
XL223
Inflammation; Inflammation Inflammation; Inflammation
Local inflammation requiring assessment in office. Topical and oral antiinflammatory meds recommende... Local inflammation requiring assessment in office. Topical and oral antiinflammatory meds recommended. More
2855019 64 F WI 08/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 GJ952
Cellulitis, Erythema, Peripheral swelling, Pruritus Cellulitis, Erythema, Peripheral swelling, Pruritus
Patient presented at clinic with swollen red, itching upper arm resulting in diagnosis of cellulitis... Patient presented at clinic with swollen red, itching upper arm resulting in diagnosis of cellulitis recieved rocephin in office and doxycycline twice daily for 7 days. More
2855020 25 F WV 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 Y004553
Antibody test, Feeling abnormal, Pyrexia, Rash Antibody test, Feeling abnormal, Pyrexia, Rash
PATIENT CALLED THE HEALTH DEPT 8/21/25 STATED THAT SHE DEVELOPED A FEVER OF 101.6 THAT LASTED FOR 2 ... PATIENT CALLED THE HEALTH DEPT 8/21/25 STATED THAT SHE DEVELOPED A FEVER OF 101.6 THAT LASTED FOR 2 DAYS APPROX 12-14 DAYS AFTER THE VACCINE AND THE DEVELOPED A RASH THAT RESEMBLED ACNE BUT IT WAS OVER HER BODY WITH AN AREA OF CLUSTERS. SHE STATED" THAT SHE FELT AWFUL." WE ADVISED HER TO COVER UP ANY PUSTLE OR MACROPAPULAR AREAS AND TO VISIT HER PCP. More
2855021 63 M VA 08/21/2025 YF
 SANOFI PASTEUR
 UK138AA
Incorrect route of product administration, No adverse event Incorrect route of product administration, No adverse event
Medication accidently administered via IM injection instead of Subcutaneous. Yellow Fever physician... Medication accidently administered via IM injection instead of Subcutaneous. Yellow Fever physician notified. Patient observed for adverse reactions, did not have any. Injection did not need to be readministered. More
2855022 4 M MO 08/21/2025 DTAPIPV
DTAPIPV
MMRV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
MERCK & CO. INC.
 5g23d
5g23d
y009348
y009348
Barrel chest, Cough, Rash, Rash erythematous, Rash macular; Respiratory distress... Barrel chest, Cough, Rash, Rash erythematous, Rash macular; Respiratory distress, Tachypnoea, Use of accessory respiratory muscles, Vomiting; Barrel chest, Cough, Rash, Rash erythematous, Rash macular; Respiratory distress, Tachypnoea, Use of accessory respiratory muscles, Vomiting More
The patient presented to Clinic on 08/18/2025 at approximately 0800 for routine immunizations. ProQu... The patient presented to Clinic on 08/18/2025 at approximately 0800 for routine immunizations. ProQuad was administered in the left thigh and Kinrix in the right thigh. The patient tolerated the injections without complication and departed the clinic at approximately 0910. At 0915, the patient?s father called reporting a new onset rash and cough. He was advised to return to the clinic for further evaluation. Upon arrival, the patient was noted to be in respiratory distress. Dr. and FNP-BC evaluated the patient. Oxygen saturation was 92% on room air. Examination revealed barrel chest, retracted breathing, and a splotchy erythematous rash across the torso. The patient also demonstrated tachypnea and vomiting. At 0950, Dr. administered Epinephrine 0.15 mg IM to the left thigh, followed by Decadron 4 mg/mL and Diphenhydramine 50 mg/mL. The patient showed an adequate response to treatment with improvement in oxygen saturation to 98% on room air and a pulse of 132 bpm. An ambulance was dispatched for transfer to Emergency Department for continued monitoring. The patient arrived at approximately 1043. He remained stable throughout observation and was prescribed Prednisolone 15 mg/5 mL for home use. The patient was discharged in stable condition at 1252. More
✓
2855023 18 M WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event, Product preparation issue No adverse event, Product preparation issue
Varicella vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and a... Varicella vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed patency of vaccination with no need to revaccinate. More
2855024 2 F WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
Proquad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) ... Proquad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed patency of vaccination with no need to revaccinate. More
2855025 0.5 M MO 08/21/2025 DTAPIPVHIB
HEP
PNC20
RV1
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
 UK232AB
AZ4TN
LN4932
7YS93
Feeling hot, Injection site reaction, Rash erythematous; Feeling hot, Injection ... Feeling hot, Injection site reaction, Rash erythematous; Feeling hot, Injection site reaction, Rash erythematous; Feeling hot, Injection site reaction, Rash erythematous; Feeling hot, Injection site reaction, Rash erythematous More
Baby started feeling warm about an hour after getting vaccines and breaking out with red bumps every... Baby started feeling warm about an hour after getting vaccines and breaking out with red bumps everywhere but especially around where the vaccine was administered. Mother was going to give baby Benadryl, Tylenol and contact PCP. Will call and check on child for follow up on how they are doing. More
2855026 1.17 M WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
Varicella vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and a... Varicella vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate More
2855027 4 M WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) ... ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate. More
2855028 43 F MI 08/21/2025 COVID19
 MODERNA
Alopecia Alopecia
Since 2 months post vax, my hair fell out in copious amounts. The first year, I lost at least 1/3 of... Since 2 months post vax, my hair fell out in copious amounts. The first year, I lost at least 1/3 of my hair. Now, still, in 2025, I lose hair in cycles. So does my 18 year old daughter who was 14 at time of "vaccination" thus making it unlikely to be a hormonal thing related to menopause. There are many of us out there- who lost a lot of hair. Please research. More
2855029 44 F TX 08/21/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
 945663
Joint swelling Joint swelling
Swelling of left shoulder 3 days after administration Swelling of left shoulder 3 days after administration
2855030 3 M WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) ... ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate. More
2855031 1 F 08/21/2025 VARCEL
 MERCK & CO. INC.
 Y003891
Needle issue Needle issue
During administration of varicella vaccine, the vaccine squirted around the needle and was not admin... During administration of varicella vaccine, the vaccine squirted around the needle and was not administered to patient. Upon assessment needle was appropriately connected to vaccine. Provider notified and parent notified, new vaccine readministered. Lot-Y003891 Ex- 2/6/2026 NDC- 0006-4827-01 More
2855032 1.42 F WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) ... ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate. More
2855033 1.5 M WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) ... ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate. More
2855034 1 F WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) ... ProQuad (MMRV) vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate. More
2855035 10 F NY 08/21/2025 HPV9
 MERCK & CO. INC.
 Z002903
Vomiting Vomiting
patient and parent stating the following 2 days after vaccine she had multiple episodes of vomiting. patient and parent stating the following 2 days after vaccine she had multiple episodes of vomiting.
2855036 27 F WI 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 1960074
No adverse event No adverse event
Varicella vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and a... Varicella vaccine was reconstituted with a potentially-expired sterile diluent (sterile water) and administered to the patient. Patient did not experience any adverse reactions. Merck was contacted and Merck confirmed potency of vaccination with no need to revaccinate. More
2855037 30 F CA 08/21/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 4T443
Exposure during pregnancy, Product use issue, Wrong product administered Exposure during pregnancy, Product use issue, Wrong product administered
Patient given Arexvy instead of Abrysvo. Pt reports EGA 35+2. Patient at risk of adverse event due t... Patient given Arexvy instead of Abrysvo. Pt reports EGA 35+2. Patient at risk of adverse event due to side effects of pregnant patient receiving Arexvy. Patient remained at clinic for one hour after event. Patient did not report any s/s of preterm labor. Patient's OB provider made aware of incident. Pt reports that her OB provider would call her to discuss what happened, possible side effects, precautions, and next steps. Incident also reported to (withheld) Clinical Consult Team (phone# withheld opt.1). More
2855038 78 F NY 08/21/2025 PNC20
 PFIZER\WYETH
Pain in extremity Pain in extremity
Ptn claims to have strong pain in the arm which has decreased but remains a week later Ptn claims to have strong pain in the arm which has decreased but remains a week later
2855039 25 F MO 08/21/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 5P2P7
Exposure during pregnancy Exposure during pregnancy
Patient came into the clinic to receive her 2nd dose of Hepatitis B vaccine but received Meningococc... Patient came into the clinic to receive her 2nd dose of Hepatitis B vaccine but received Meningococcal B instead, patient is currently pregnant and was 6 months pregnant during the time of vaccination. More
2855040 52 F TX 08/21/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 2HJ99
2HJ99
Erythema, Feeling hot, Headache, Influenza like illness, Pyrexia; Rash Erythema, Feeling hot, Headache, Influenza like illness, Pyrexia; Rash
Pt showed up at pharmacy on 8/21/25 with concerns about possible allergic rxn with shingrix vaccine ... Pt showed up at pharmacy on 8/21/25 with concerns about possible allergic rxn with shingrix vaccine dose given on 8/18/25. Pt reported a brief episodes of SOB that went away after a few seconds after receiving the vaccine on 8/18/25. Pt reported mild headache that appeared 2 days after vaccine admin, feverish, flu-like symptoms that appeared 2 days after vaccine admin as well. Upon visual examination, Pt's arm showed signed of local reaction such as warmth, erythema, (swelling that happened the day before and went down). Rash appeared to migrate. RPh on duty troubleshoot Pt's reports of symptoms and explained to Pt that all the local reactions happened to Pt as well as systemic adverse reactions and that those are common with shingrix vaccine and vaccines in general. Prior to going to the pharmacy today, Pt went to seek advice at local pharmacy and was told by RPh that her local reaction was possibly due to too low or too high site of vaccine administration. RPh on duty demonstrated the technique to the Pt and concluded that it was a proper site for administration and to reiterate to Pt that all her symptoms are norm al adverse reactions that were reported in the literature as high incidence of occurrence and local reactions are normal with vaccine in general, which is an indication of her immune system and the vaccine are working well the way it was supposed to. RPh on duty counseled Pt to continue taking benadryl 25mg q46h prn redness, motrin q6h prn swelling and pain , hydrocortisone 1% crm for redness, icepack for pain/swelling. Pt was also counseled to continue monitoring her erythema and make sure it does not spread any further and if it does, she should go see her PCP or urgent care. Pt was reassured that no vaccine errors or error in administration occurred and seemed to be understanding about it. Pt was counseled risk vs benefits, even though erythema and rash might occur with the vaccine but the vaccine is every effective so it's still more beneficial for her to get her second dose and maybe some post-admin meds such as benadryl and motrin/apap should be taken after receiving the vaccine. More
2855041 12 F CA 08/21/2025 TDAP
VARCEL
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 ze4n7
z004246
Loss of consciousness; Loss of consciousness Loss of consciousness; Loss of consciousness
Very nice girl, came in with her mom, vaccinated her and then we stayed in the vaccine room for a fe... Very nice girl, came in with her mom, vaccinated her and then we stayed in the vaccine room for a few minutes while I finished filling out her vaccination immunization record for the day. then we walked together out the vaccine room to the register. While ringing them out at the register patient appeared to lean against her mom and put her face into her arm/shoulder area, and then she slide down her moms side to the floor passed out. I jumped to the floor to hold her head, we remained on the floor for a few minutes before transferring to chair. She was passed out but breathing, took 10 seconds or so and she blinked and woke. was able to get up and sit in the waiting room chairs with her mom. They stayed here at least another 20min. We provided water, snacks, cold compress on her neck head and chest. She did not hit her head with the way she slid and fell off her mom. We did call to check on her on 08/18/2025, mail box full no way to leave message. More
2855042 66 F CA 08/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 5Y9CA
Herpes zoster, Rash Herpes zoster, Rash
Patient developed shingles rash 6 hours after vaccination Patient developed shingles rash 6 hours after vaccination
2855043 37 F NV 08/21/2025 COVID19
HEP
HPV9
 PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.


Lip swelling, Urticaria; Lip swelling, Urticaria; Lip swelling, Urticaria Lip swelling, Urticaria; Lip swelling, Urticaria; Lip swelling, Urticaria
Many hours after the shot, I developed hives, which eventually covered about 80% of my body. My top ... Many hours after the shot, I developed hives, which eventually covered about 80% of my body. My top lip swelled but I did not have any breathing trouble. My doctor sent a steroid and now they are starting to go away, 2 days later. More
2855044 2 M IL 08/21/2025 DTAP
MMR
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.

Pyrexia, Rash, Urticaria; Pyrexia, Rash, Urticaria Pyrexia, Rash, Urticaria; Pyrexia, Rash, Urticaria
Developed fever and urticarial rash x 3d post injection. Rash progressively spread throughout entire... Developed fever and urticarial rash x 3d post injection. Rash progressively spread throughout entire body - scalp, face, neck, trunk, arms/hands, legs/feet, buttocks/groin. More
2855045 85 M MO 08/21/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 429P7
Product preparation issue Product preparation issue
Vaccine was not reconstituted prior to administration, pharmacist injected syringe of only diluent. Vaccine was not reconstituted prior to administration, pharmacist injected syringe of only diluent.
2855046 5 F CA 08/21/2025 DTAP
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 497n7
z008223
Injection site swelling; Injection site swelling Injection site swelling; Injection site swelling
Came to our pharmacy for vaccines needed for school, no issues while here, left feeling fine. We cal... Came to our pharmacy for vaccines needed for school, no issues while here, left feeling fine. We called parent a couple days later for some insurance information clarification, on 08/13/2025- Dad reported her mmrv vaccine leg was swollen at injection site size of a baseball. We recommended Tylenol, cold compress and movement, and to follow up with provider or go to emergency room if it worsens. More
2855047 4 F CA 08/21/2025 DTAPIPV
MMRV
 SANOFI PASTEUR
MERCK & CO. INC.
 u8009ab
y019464
Pallor, Syncope; Pallor, Syncope Pallor, Syncope; Pallor, Syncope
PT WAS PALE,FAINTED PT WAS PALE,FAINTED
2855048 14 F MI 08/21/2025 MMR
MMR
 MERCK & CO. INC.
MERCK & CO. INC.
 Y013132
Y013132
Asthenia, Disorientation, Dizziness, Feeling hot, Head injury; Loss of conscious... Asthenia, Disorientation, Dizziness, Feeling hot, Head injury; Loss of consciousness, Pallor, Syncope More
Client started walking down the hallway and fainted, hit the left side of her head on door frame. Br... Client started walking down the hallway and fainted, hit the left side of her head on door frame. Briefly lost consciousness (a few seconds), and was disoriented, pale and felt weak and dizzy when she came to. She said she felt hot, temp was 97.2 F. She stated her throat felt a little funny and the left side of her neck and head hurt. There was no active bleeding or broken skin noted. She stated she had not eaten. BP was 100/60 and RR 18. Pupuls were equal and reactive to light. Given a juice and a granola bar and put a fan on her, encouraged to stay on the floor until she felt a little better. Her throat was feeling better once she had a couple drinks of juice. She became oriented and regained memory of the situation within 5-10 minutes. Her color began to improve. Discussed syncope after vaccinations with mom, and advised to have her eat something with protein before receiving any injections. Also discussed plan for future imms or other injections to be given sitting or laying (preferably laying) and to have her stay for observation and refrain from getting up directly afterwords. Mom agreed. Advised they seek further assessment due to hitting her head, and mom agreed. She was able to get herself into a wheelchair with supervisoin, and I wheeled her out to the vehicle and assisted her (spotting) into the passenger's seat. Encouraged mom to go straight to the ER ad that I would let them know they are coming, and she agreed. I let her know also that I would check in with them the next day and she requested this be done via text due to poor service at work. Report given to ER at 5:56 pm while patient and her mom were en route. More
2855049 11 F CA 08/21/2025 HEPA
HPV9
MNQ
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
 dn273
z005055
9x7cd
xn575
Dizziness, Nausea, Pallor; Dizziness, Nausea, Pallor; Dizziness, Nausea, Pallor;... Dizziness, Nausea, Pallor; Dizziness, Nausea, Pallor; Dizziness, Nausea, Pallor; Dizziness, Nausea, Pallor More
After receiving the final & fourth vaccine, patient stated she was dizzy, was extremely nauseous... After receiving the final & fourth vaccine, patient stated she was dizzy, was extremely nauseous, pale white, we alerted pharmacists, who assessed, we provided water & a trashcan- she held onto it hovering over it for about 5 minutes while experiencing the nausea, continued to monitor for 15 minutes afterward. More
2855050 11 F MA 08/21/2025 MNQ
TDAP
 SANOFI PASTEUR
SANOFI PASTEUR
 U8493AA
3CA30C1
Injection site erythema; Injection site erythema Injection site erythema; Injection site erythema
localized reaction- redness worsening on injection site localized reaction- redness worsening on injection site
2855051 14 F MD 08/21/2025 UNK
 UNKNOWN MANUFACTURER
 95bj9
Wrong product administered Wrong product administered
I reviewed the patient?s chart at my desk to confirm the vaccine due. I then proceeded to the medica... I reviewed the patient?s chart at my desk to confirm the vaccine due. I then proceeded to the medication room to retrieve the vaccine and believed I had selected the correct one. After scanning the vaccine in the room, I administered it to the patient. However, I later realized that the incorrect vaccine had been given. I promptly informed the provider and my supervisor, who have since spoken with the parent regarding the situation. More
2855052 90 F NY 08/21/2025 PNC20
PNC20
 PFIZER\WYETH
PFIZER\WYETH
 LN4932
LN4932
Immediate post-injection reaction, Injection site pain, Loss of personal indepen... Immediate post-injection reaction, Injection site pain, Loss of personal independence in daily activities, Mobility decreased, Tendon calcification; X-ray limb abnormal More
On August 13, 2025, I gave this patient a Pneumococcal Conjugate 20 Valent (Prevnar 20 PCV 20) intra... On August 13, 2025, I gave this patient a Pneumococcal Conjugate 20 Valent (Prevnar 20 PCV 20) intramuscular injection vaccine in her right deltoid muscle. The patient immediately complained of a pain in her deltoid muscle. I attributed this to the vaccine solution can sting sometimes at the injection site. I instructed the patient to move her arm around today and tomorrow, putting the deltoid muscle through range of motion. If her arm hurts, she can take whatever she takes for a headache, and if the site becomes warm or swollen she can apply ice to the site. On August 19, 2025: the patient's daughter called because the patient received the pneumonia vaccine and she has minimal ROM and still in quite a bit of pain. No redness or swelling. Per Dr.: the patient needs to go to urgent care tonight and then be seen in the office tomorrow at 12:45. Verbalized understanding and will contact the office if needed. Pt scheduled for 8/20/25 at 12:45 as per Dr. On August 20, 2025 "the patient is here for complaint of arm pain after she was given an injection last week. The patient presents for evaluation of joint pain/weakness in the arm following a pneumococcal vaccine. According to the patient the pain was significant enough to limit her arm mobility, requiring assistance from her aunt for daily activities such as hair combing and dressing. She sought medical attention at an urgent care facility, where she was prescribed prednisone. An x-ray revealed age-related changes and calcification in the rotator cuff. According to the daughter the injection may have aggravated a pre-existing condition. The attending physician at the urgent care recommended a follow-up with orthopedics and possibly an injection of prednisone if not fully alleviate the symptoms. She is currently on a 6-day course of prednisone, which has significantly improved her condition, allowing her to lift her arm. She also took Tylenol and Advil for pain management. joint pain post-vaccination: Acute. - Likely due to nerve damage from the pneumococcal vaccine. Significant pain immediately after the injection, with initial inability to move the arm, which has improved but still causes discomfort. Improved range of motion in the arm compared to yesterday, but there is still pain upon resistance. X-ray showed age-related changes and calcification in the rotator cuff, per report from the daughter - Prednisone regimen to reduce inflammation." More
2855053 20 F NY 08/21/2025 MNQ
 SANOFI PASTEUR
Pyrexia, Urticaria Pyrexia, Urticaria
mother reported allergic reaction to meningitis vaccine, reported subjective fever at following nigh... mother reported allergic reaction to meningitis vaccine, reported subjective fever at following night and hives all over her body in the morning. Improved after 1 dose of benadryl. Denied anaphylaxis sx. rec: zirtec daily for 1-2 days and discussed anaphylaxis ssx. More
2855054 5 M UT 08/21/2025 DTAPIPV
 SANOFI PASTEUR
 U8209CB
Joint swelling, Rash Joint swelling, Rash
Patient had swelling of the right knee and a rash Patient had swelling of the right knee and a rash
📋 Privacy Policy & Data Disclaimer